However, comparing the positivity in both β-amyloid and tau biomarkers indicated no significant sex differences in Alzheimer’s disease co-pathology in our DLB cohort, making a sex-specific impact on grey matter networks improbable. The gene discussed is MAPT; the disease is Lewy body dementia.